Millets National Media Portal
Millets National Media Portal
Emerging research suggests millets — particularly proso millet and finger millet — offer meaningful hepatoprotective benefits relevant to NAFLD management. NAFLD, now affecting approximately 25% of the global adult population (Hepatology International, 2022), is closely linked to insulin resistance, dyslipidemia, and metabolic syndrome — all conditions that millets are known to address.
How millets protect against NAFLD:
Proso millet protein: PMC-indexed research confirms that proso millet protein is effective in preventing liver injury even at lower dietary protein levels compared to dietary gluten — suggesting hepatoprotective mechanisms unique to millet proteins.
Finger millet amino acids: Threonine, methionine, and lecithin (thionine, threonine in finger millet) contribute to removing excess hepatic fat, lowering cholesterol synthesis, and preventing abnormal fat accumulation in liver cells (Discover Food, Springer Nature, 2024).
Lipid metabolism improvement: Dietary fiber in millets reduces intestinal fat absorption and interrupts enterohepatic cholesterol recycling, reducing hepatic lipid burden.
Insulin sensitization: Improved insulin sensitivity from millet's low-GI bioactive compounds reduces hyperinsulinemia — a primary driver of hepatic de novo lipogenesis in NAFLD.
Antioxidant liver protection: Quercetin and ferulic acid protect hepatocytes from oxidative stress-induced lipid peroxidation, a key mechanism in NAFLD progression to NASH (non-alcoholic steatohepatitis).
Gut-liver axis: Millet's prebiotic fiber supports a healthy gut microbiome, reducing production of lipopolysaccharides (LPS) that trigger hepatic inflammation through the portal blood-liver pathway.
Important caveat: Clinical human trials specifically on millets and NAFLD are still limited; most evidence comes from experimental models and indirect nutritional studies — larger human RCTs are needed.
© 2023 - 2026 Millets News. All rights reserved.
